Beam Walking Across the Lifespan for Falls Prediction
NCT03532984, Unknown, University Medical Center Groningen
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Beam Walking Across the Lifespan for Falls Prediction | ClinicalTrials.gov |
| NCT number | NCT03532984 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Enrollment | 432 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | University Medical Center Groningen | ClinicalTrials.gov |
| Conditions | Aging, Parkinson Disease, Stroke, Dementia, Diagnoses Disease, Cognitive Impairment, Postural; Defect | ClinicalTrials.gov |
| Interventions | Beam test to predict falls | ClinicalTrials.gov |
| First posted | 2018-05-22 | ClinicalTrials.gov |
| Last updated | 2018-05-22 | ClinicalTrials.gov |
Registered outcomes 18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | distance in balance beam walking under single and dual-task conditions | 2 hours | Outcomes are the sum of length traversed (3-5 trials, 4m each, 12m maximum), average velocity, number of steps, and average step length determined from video tape recordings (60Hz) made at 90° relative to the walking direction with full beam length in view using off-the-shelf HD video cameras (Kinovea software). | ClinicalTrials.gov |
| Secondary | Physical activity | 10 minutes | Physical activity will be estimated by the international physical activity questionnaire in all participants | ClinicalTrials.gov |
| Secondary | Fall history | 10 minutes | Fall history will be determined by having participants age 50+ report falls for the previous 12 months ('Have you experienced a fall over the past 12 months? 'How severe was the most severe fall? (Hospitalization, fracture, nursing home admission).' Patients' hospital fall records will be also consulted if available. | ClinicalTrials.gov |
| Secondary | Falls efficacy scale-international | 10 minutes | Falls efficacy scale-international will determine in participants age 50+ the level of concern about falling during social and physical activities indoors and outdoors. 16-items are being asked on a 4-point Likert scale. The scores are added up to calculate a total score that ranges from 16 to 64. A higher score indicates a greater fear of falling. | ClinicalTrials.gov |
| Secondary | Balance confidence | 15 minutes | Balance confidence will be assessed with the Activities-specific Balance Confidence (ABC) Scale. The scale is in % from 0 (no confidence) to 100 (completely confident) | ClinicalTrials.gov |
| Secondary | Mini-BESTest | 20 minutes | Mini-BESTest identifies systems that control (dynamic) balance. | ClinicalTrials.gov |
| Secondary | Mobility | 20 minutes | Mobility will be measured in all participants by the Short Physical Performance Battery, a composite mobility test. | ClinicalTrials.gov |
| Secondary | Static steady-state balance | 10 minutes | Static steady-state balance will be assessed in all participants using the Romberg and Sharpened Romberg Tests while standing on a force platform with feet closed while holding both arms extended to the front with palms facing upwards and in tandem stance with eyes open and closed for 10s each task. | ClinicalTrials.gov |
| Secondary | Proactive Balance | 10 minutes | Proactive balance will be measured in all participants age 20-29 and 50+ by the functional reach test while standing on a force platform | ClinicalTrials.gov |
| Secondary | Reactive balance | 10 minutes | Reactive balance will be measured in all participants age 20-29 and 50+ by the push and release test | ClinicalTrials.gov |
| Secondary | Upper extremity strength | 10 minutes | Upper extremity strength will be measured in all participants by grip strength | ClinicalTrials.gov |
| Secondary | Lower extremity strength | 10 minutes | Lower extremity strength of the knee extensors will be measured in all participants in the seated position on a dynamometer or by a hand held dynamometer | ClinicalTrials.gov |
| Secondary | Cognitive status | 5 minutes | Cognitive status will be measured in all participants by the Digit Symbol Substitution Test | ClinicalTrials.gov |
| Secondary | Global cognition | 5 minutes | Global cognition will be measured in participants aged 50+ by the Mini Mental State Examination Test | ClinicalTrials.gov |
| Secondary | Executive function | 5 minutes | Executive function will be measured in participants aged 50+ by the phonemic fluency test | ClinicalTrials.gov |
| Secondary | Attention | 5 minutes | Attention will be measured in participants aged 50+ by the Stroop color-word test | ClinicalTrials.gov |
| Secondary | Verbal memory span | 10 minutes | Verbal memory span will be measured in participants aged 50+ by the Digit Span test | ClinicalTrials.gov |
| Secondary | Visual memory span | 10 minutes | Visual memory span will be measured in participants aged 50+ by the Visual Memory Span test | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 2
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Symbol Coding | Secondary outcome | ConductCognition |
| Verbal Fluency | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)